HER2 Inhibitors Market

HER2 regulates cell growth, survival and differentiation through a variety of signal transduction pathways.Several cancers, including breast, stomach and ovarian, are on the rise because of overexpression of HER2, which is inhibited by HER2 inhibitors
HER2 Inhibitors Market aims to provide a comprehensive presentation of the global market for HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors. HER2 Inhibitors Market contains market size and forecasts of HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors in global, including the following market information:
Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Monotherapy Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors include F. Hoffmann-La Roche Ltd, Merck & Co., Inc, Novartis AG, Pfizer Inc and Puma Biotechnology, Inc, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Segment Percentages, by Type, 2022 (%)
Monotherapy
Combination Therapy
Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Segment Percentages, by Application, 2022 (%)
Breast Cancer
Gastric Cancer
Ovarian Cancer
Others
Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
F. Hoffmann-La Roche Ltd
Merck & Co., Inc
Novartis AG
Pfizer Inc
Puma Biotechnology, Inc
Outline of Major Chapters:
Chapter 1: Introduces the definition of HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors, market overview.
Chapter 2: Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors market size in revenue.
Chapter 3: Detailed analysis of HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.